Home
Who we are
Who we are
Overview
Chairman's Profile
Board of Directors
Team Wockhardt
Collaborations / Partnerships
Faclities
Manufacturing
Contract Manufacturing
Virtual Tour
Global Presence
Our Footprints
Other websites
Community Care
Wockhardt Foundation
We touch lives
R & D
Overview
Generics
New Drug Discovery
Biotechnology
Overview
Biopharmaceuticals
Biotechnology Park
Gallery
Corporate Regulatory
Marketing & Regulatory Infrastructure
Products
Search Products
People
Frequently Asked Questions
Life at Wockhardt
Focus on Development
Wockhardt Anthem
Meet our People
Wockhardt on LinkedIn
Career Openings
Investors
Financials at a glance
Annual Reports
AGM Notice
Chairman's AGM Speeches
Other Shareholders Services
Quarterly Results
Financial Press Releases
Chairman's letter to Shareowners
Details of Unclaimed Dividend
Filings with Stock Exchange
Shareholding Pattern
Stock Quotes
Statutory Communication
Policies
Credit Rating
Investor Communication
Investor Meet
Investor Contact
Investor Call
Accounts of Subsidiaries
Media & Press
Media coverage
Press Release
Media Kit
Media Contact
CSR
CSR Policy
Report on CSR activities – Wockhardt Foundation
CSR Strategy
Quarterly Report
Stakeholders Engagement
Home
>
Media
>
Press Releases
>
Wockhardt and Serum Life Sciences UK announce collaboration for manufacturing multiple vaccines in the United Kingdom
Press Releases
< back
Wockhardt and Serum Life Sciences UK announce collaboration for manufacturing multiple vaccines in the United Kingdom
20 March, 2022
prc-21322